📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
15
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ACLS.
💹 Market Data
Market Cap$4.78B
Shares Outstanding30.73M
Float30.55M
Cash$366.60M
Debt$70.50M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 2.5% shares (2025Q4 vs prior)
368 institutional holders · 32.12M shares
#1
BlackRock, Inc.
4.83M shares
#2
VANGUARD GROUP INC
4.12M shares
#3
VICTORY CAPITAL MANAGEMENT INC
1.81M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest2.99M
Days to Cover3.8
% of Float9.9%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Mar 26, 2026
3
FORM3
Mar 25, 2026
3
FORM3
Mar 24, 2026
4
INSIDER TRANSACTION
Mar 03, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ACLS
📊 ACLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ACLS Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.